XJPX
4320
Market cap172mUSD
Oct 09, Last price
1,631.00JPY
1D
0.00%
1Q
-7.49%
Jan 2017
494.17%
IPO
25.46%
Name
CE Holdings Co Ltd
Chart & performance
P/E
17.46
P/S
1.72
EPS
93.42
Div yield, %
3.19%
Shrs. gr., 5y
0.98%
Rev. gr., 5y
8.35%
Revenues
15.83b
+8.77%
Net income
1.56b
+1,162.20%
CFO
998m
+32.69%
Dividend
Sep 29, 202624 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CE Holdings Co., Ltd., operating through its subsidiaries in Japan, specializes in the development and sale of electronic medical record (EMR) and comprehensive medical information systems. Its product portfolio includes MI RA Is (Miraize), a notable EMR system tailored for healthcare facilities. The entity, initially known as CEI Corporation, rebranded to CE Holdings Co., Ltd. in April 2013. Established in 1996, the company maintains its headquarters in Sapporo, Japan.
Key people
Tsunehito Taguchi
Chief Financial Officer, Director · since 2021
Kaori Fujimoto
Chief Human Resources Officer, Director · since 2025
Keiichi Haga
Managing Director, Manager of Corporate and Business Planning Office, Chief Strategy Officer · since 2021
Yoshitaka Matsuzawa
Senior Managing Director, Chief Risk Officer · since 2021
Masanori Niizato
President, Chief Operating Officer, Representative Director · since 2024
Yasuaki Sugimoto
Chairman of the Board, Chief Executive Officer, Representative Director · since 2024
Hidenori Asami
Independent Director · since 2025
Takeji Dehara
Independent Director · since 2024
Mika Hoshika
Independent Director · since 2023
Shuji Yoshida
Independent Director · since 2015
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||